NNNattika Nimmano

Nattika Nimmano

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Nattika Nimmano has a total of 19 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Development of azithromycin-loaded nanostructured lipid carriers for nebulized delivery in cystic fibrosis-associated Pseudomonas aeruginosa infections

    by Nandar Tint Lwin, Veerakiet Boonkanokwong, Wongsakorn Phongsopitanun, Ungkarn Jarujareet, Papon Muangsanit, Sudartip Areecheewakul, Jittima Chatchawalsaisin, Nattika Nimmano

  • Open Access

    Development and Characterization of Celecoxib-Loaded Soluplus/Zein Composite Nanoparticles Coated with Chitosan for Pulmonary Drug Delivery

    by Khin Cho Nyein, Maxius Gunawan, Papon Muangsanit, Sudartip Areecheewakul, Jittima Chatchawalsaisin, Nattika Nimmano

    Non-small cell lung cancer (NSCLC), the most common subtype of lung cancer, remains a major contributor to cancer-related mortality worldwide. Celecoxib, a selective cyclooxygenase-2 (COX-2) inhibitor, has beenrepurposed as an anticancer agent for NSCLC therapy. In the present study, celecoxib-loaded Soluplus/zein composite nanoparticles coated with chitosan were successfully developed and evaluated as a promising pulmonary drug delivery system for NSCLC. The nanoparticles were prepared using an antisolvent precipitation technique and demonstrated favorable physicochemical properties. The optimized formulation exhibited a particle size of approximately 190 nm with high encapsulation efficiency (85.34%), and high drug-loading capacity (14.21%). The chitosan coating increased the zeta potential to nearly +30.42 mV, yielding enhanced stability and desirable mucoadhesive properties for pulmonary administration. In vitro release studies revealed sustained release under simulated physiological lung conditions, following diffusion- and swelling-controlled release mechanisms. Cytotoxicity evaluation using the MTT assay demonstrated significant anticancer activity against A549 lung cancer cells while maintaining good biocompatibility toward BEAS-2B normal human bronchial epithelial cells. The optimized nanoparticles also showed efficient transport across an air–liquid interface (ALI) airway epithelial barrier, with a Papp value of 4.15 × 10–4 cm·s–1 and 0.38% translocation after 24 h. Furthermore, aerosolized nanoparticles displayed excellent aerodynamic performance, with a fine particle fraction (FPF) of 68.51% and a mass median aerodynamic diameter (MMAD) of 3.93 μm using the Next Generation Impactor (NGI). Overall, these findings highlight the potential of celecoxib-loaded Soluplus/zein nanoparticles coated with chitosan as a promising pulmonary drug delivery system for NSCLC via nebulization.


  • Open Access

    Preparation, characterization and evaluation of microemulsions containing Clausena excavata Burm. f. leaf essential oil

    by Nandar Tint Lwin, Thanarat Salahong, Wongsakorn Phongsopitanun, Paranee Sripreechasak, Chatchai Chaotham, Nonthalert Lertnitikul, Nonthaneth Nalinratana, Nattika Nimmano

    Clausena excavataBurm. f. (Rutaceae), a tropical plant widely used in traditional medicine, contains bioactive compounds, including essential oils with ant


  • Open Access

    Preparation and evaluation of Dendrobium formosum extract-loaded microemulsions for anti-aging purpose

    by Suradwadee Thungmungmee, Boonchoo Sritularak, Nakuntwalai Wisidsri, Nattika Nimmano

    Skin aging is a complex process caused by oxidative stress, leading to a growing need for cosmeceuticals with effective antioxidant and matrix metalloproteinase-1 (MMP-1) inhibitory activities. D. formosum has shown various biological activities; however, an appropriate delivery system is required to enhance its efficacy. Our study firstly explored the protective effects of D. formosum extract on UVB-irradiated human keratinocytes (HaCaT) and human fibroblasts (BJ), and then developed topical microemulsion (ME) containing D. formosum extract. Our results show that D. formosum extract demonstrates anti-aging properties by reducing intracellular reactive oxygen species (ROS) in UVB-irradiated HaCaT and BJ, and inhibiting MMP-1 expression. Pseudo-ternary phase diagrams were constructed using the water titration method. The optimized microemulsion base (MEB) contained trilaureth-4 phosphate: propylene glycol (surfactant: cosurfactant; 2:1, 57.50%), isononyl isononanoate (oil, 17.50%), and deionized water (25.00%). The 0.40% w/w D. formosum extract, called DME1, was loaded into the MEB. This formulation exhibited desirable characteristics, including size, polydisperse index (PDI), zeta potential, and viscosity. DME1 was physicochemically and chemically stable. The DME1 also significantly increase skin retention and was safe to human skin cells. Our findings highlight D. formosum extract as a novel active ingredient and its potentially topical delivery for anti-aging purpose.


  • Open Access

    Exploring Anti-Aging Potential of Dendrobium Species and Novel Microemulsion Delivery of Dendrobium kentrophyllum Extract for Anti-Aging Effect

    by Suradwadee Thungmungmee, Boonchoo Sritularak, Nakuntwalai Wisidsri, Nattakan Kanana, Nattika Nimmano

    Purpose: The study aimed to investigate in vitro anti-aging activities of 29 Dendrobium spp. and develop and characterize microemulsions (MEs) for topical application. Methods: Antioxidant activity was determined using 2,2-diphenyl-1-picrylhydrazyl (DPPH), H2O2 scavenging, and ferric reducing antioxidant power (FRAP) assays. The anti-collagenase (MMP-1 and MMP-2) and anti-elastase activities were also evaluated. Cytotoxicity and human intracellular reactive oxygen species (ROS) levels were determined using resazurin reduction and 2′,7′-dichlorofluorescin diacetate (DCFDA) assays, respectively. D. kentrophyllum extract-loaded microemulsion (DKME) was then prepared and optimized. The stability of DKME was studied using a heating-cooling cycle. Results: D. kentrophyllum appeared to be the best candidate anti-aging agent because of its antioxidant, anti-collagenase, and anti-elastase activities. The extract was safe for human skin cells at a concentration of 6.25– 100 μg/mL. It also decreased the intracellular ROS-induced ultraviolet B (UVB) irradiation compared to that in the control. DKME comprising Tween 80:ethanol (5:1), water, and isononyl isononanoate showed a suitable appearance, droplet size, polydisperse index, zeta potential, pH, and viscosity. This formulation demonstrated desirable physical and chemical stability, with non-cytotoxic effects. Conclusion: DKME is considered a promising anti-aging product. However, an in vivo study of this optimized formulation might be evaluated in further study for anti-aging purposes.